As previous studies have found that cell migration and EMT were inhibited by oridonin in pancreatic cancer31 and breast cancer,32 we have been suggested that the effect of oridonin on inhibiting EMT is associated with increased E‐cadherin expression. Here, CDH1 is linked to breast cancer.